At the time of writing, Rein Therapeutics Inc [RNTX] stock is trading at $1.19, up 6.25%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The RNTX shares have gain 3.48% over the last week, with a monthly amount glided 0.85%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Rein Therapeutics Inc [NASDAQ: RNTX] stock has seen the most recent analyst activity on September 22, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $10. Previously, Rodman & Renshaw started tracking the stock with Buy rating on January 28, 2025, and set its price target to $8. On July 24, 2017, William Blair initiated with a Outperform rating. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $20 on July 24, 2017. BofA/Merrill initiated its recommendation with a Buy and recommended $19 as its price target on July 24, 2017.
For the past year, the stock price of Rein Therapeutics Inc fluctuated between $1.04 and $4.40. Rein Therapeutics Inc [NASDAQ: RNTX] shares were valued at $1.19 at the most recent close of the market.
Analyzing the RNTX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.93, Equity is -1.9 and Total Capital is -1.23.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.1433 points at the first support level, and at 1.0967 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.2233, and for the 2nd resistance point, it is at 1.2567.
Ratios To Look Out For
It is important to note that Rein Therapeutics Inc [NASDAQ:RNTX] has a current ratio of 0.86. As well, the Quick Ratio is 0.86, while the Cash Ratio is 0.74.
Transactions by insiders
Recent insider trading involved WINDSOR JAMES BRIAN, President and CEO, that happened on Dec 05 ’24 when 400.0 shares were purchased.
